APPOINTMENTS

• Principal Investigator, National Heart Research Institute Singapore, National Heart Centre Singapore
• Associate Professor, Duke-NUS Medical School, Singapore, 2019 - Present
  

PUBLICATIONS

• Berry JL,Zhu WQ, Tang YL, Krishnamurthy P, Ge Y,Cooke JP, Chen YB, Garry DJ, Yang HT,Rajasekaran NS,Koch WJ,Li S, Domae K, Qin GJ, Cheng K, Kamp TJ, Ye L, Hu SJ, Ogle BM, Rogers JM, Abel ED, Davis ME, Prabhu SD,Liao RL, Pu WT, Wang YB,Ping PP, Bursac N, Vunjak-Novakovic G, Wu JC, Bolli R, Menasché P, Zhang JY. Circ Res. 2019 Jan.; 124(1): 161-169.
• Ye L, D'Agostino G, Loo SJ, Wang CX, Su LP, Tan SH, Tee GZ, Pua CJ, Pena EM, Cheng RB, Chen WC, Abdurrachim D, Lalic J, Tan RS, Lee TH, Zhang JY, Cook SA, Early regenerative capacity in the porcine heart. Circulation 2018 Dec.;138(24): 2798-2808. (Corresponding author)
• Su LP, Kong XC, Lim SY, Loo SJ, Tan SH, Poh KK, Dutton J, Stewart C, Cook S, Su XF, Ma JH, Zhang JY, Ye L. The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways. Stem Cell Research and Therapy. 15 Nov. 2018. 9:313. (Corresponding author)
• Tan SH, and Ye L. Maturation of pluripotent stem cells derived cardiomyocytes: a critical step for drug discovery and cell therapy. J Cardiovasc Transl. Res. 2018 Oct;11(5): 375-392. JIF=2.319. (Corresponding author)
• Ye L, Chang YH, Xiong Q, Zhang PY, Zhang LY, Somasundaram P, Lepley M, Swingen C, Su LP, Wendel JS, Guo J, Jang A, Rosenbush D, Greder L, Dutton JR, Zhang JH, Kamp TJ, Kaufman DS, Ge Y, Zhang JY. Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 2014; 15(6): 750-761.

AWARDS & ACHIEVEMENTS